nodes	percent_of_prediction	percent_of_DWPC	metapath
Melphalan—Alkylating Activity—Temozolomide—melanoma	0.333	0.368	CiPCiCtD
Melphalan—Alkylating Activity—Carmustine—melanoma	0.305	0.337	CiPCiCtD
Melphalan—Alkylating Activity—Dacarbazine—melanoma	0.266	0.295	CiPCiCtD
Melphalan—SLC7A5—Basigin interactions—BSG—melanoma	0.00154	0.0647	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—ARNT—melanoma	0.00129	0.0542	CbGpPWpGaD
Melphalan—SLC7A5—Amino acid and oligopeptide SLC transporters—SLC15A2—melanoma	0.00128	0.0536	CbGpPWpGaD
Melphalan—SLC22A3—Abacavir transmembrane transport—ABCB1—melanoma	0.00123	0.0516	CbGpPWpGaD
Melphalan—SLC7A5—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	0.00123	0.0516	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—CEACAM1—melanoma	0.00105	0.044	CbGpPWpGaD
Melphalan—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—melanoma	0.000752	0.0315	CbGpPWpGaD
Melphalan—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	0.000723	0.0304	CbGpPWpGaD
Melphalan—SLC7A5—Basigin interactions—ITGB1—melanoma	0.000707	0.0297	CbGpPWpGaD
Melphalan—SLC22A3—Abacavir transport and metabolism—ABCB1—melanoma	0.000707	0.0297	CbGpPWpGaD
Melphalan—SLC7A5—Basigin interactions—MMP1—melanoma	0.00055	0.0231	CbGpPWpGaD
Melphalan—Transaminases increased—Carmustine—melanoma	0.000532	0.00749	CcSEcCtD
Melphalan—Interstitial lung disease—Bleomycin—melanoma	0.000524	0.00737	CcSEcCtD
Melphalan—Febrile neutropenia—Temozolomide—melanoma	0.00052	0.00732	CcSEcCtD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—BSG—melanoma	0.000512	0.0215	CbGpPWpGaD
Melphalan—SLC7A5—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	0.00051	0.0214	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—CYP1B1—melanoma	0.000497	0.0209	CbGpPWpGaD
Melphalan—Pulmonary fibrosis—Docetaxel—melanoma	0.000473	0.00665	CcSEcCtD
Melphalan—Atrial fibrillation—Vemurafenib—melanoma	0.000469	0.0066	CcSEcCtD
Melphalan—Digestion impaired—Temozolomide—melanoma	0.000468	0.00658	CcSEcCtD
Melphalan—Interstitial lung disease—Carmustine—melanoma	0.000457	0.00643	CcSEcCtD
Melphalan—Myelosuppression—Docetaxel—melanoma	0.000443	0.00624	CcSEcCtD
Melphalan—Interstitial lung disease—Temozolomide—melanoma	0.000442	0.00622	CcSEcCtD
Melphalan—Interstitial pneumonia—Docetaxel—melanoma	0.00043	0.00606	CcSEcCtD
Melphalan—Extravasation—Bleomycin—melanoma	0.000425	0.00598	CcSEcCtD
Melphalan—Extravasation—Dactinomycin—melanoma	0.000396	0.00558	CcSEcCtD
Melphalan—Ulcer—Bleomycin—melanoma	0.000392	0.00552	CcSEcCtD
Melphalan—Extravasation—Carmustine—melanoma	0.000371	0.00522	CcSEcCtD
Melphalan—Foetor hepaticus—Docetaxel—melanoma	0.000366	0.00516	CcSEcCtD
Melphalan—Ulcer—Dactinomycin—melanoma	0.000365	0.00514	CcSEcCtD
Melphalan—Cystitis noninfective—Bleomycin—melanoma	0.000362	0.0051	CcSEcCtD
Melphalan—Cystitis—Bleomycin—melanoma	0.000358	0.00504	CcSEcCtD
Melphalan—Amenorrhoea—Temozolomide—melanoma	0.000356	0.00501	CcSEcCtD
Melphalan—Skin exfoliation—Bleomycin—melanoma	0.000354	0.00498	CcSEcCtD
Melphalan—Febrile neutropenia—Docetaxel—melanoma	0.000346	0.00487	CcSEcCtD
Melphalan—Ibuprofen—BCL2—melanoma	0.000336	0.334	CrCbGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC15A2—melanoma	0.000336	0.0141	CbGpPWpGaD
Melphalan—Neuropathy peripheral—Vemurafenib—melanoma	0.000335	0.00472	CcSEcCtD
Melphalan—Bladder pain—Bleomycin—melanoma	0.000335	0.00472	CcSEcCtD
Melphalan—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A11—melanoma	0.000329	0.0138	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ABCB5—melanoma	0.000325	0.0136	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.000323	0.0136	CbGpPWpGaD
Melphalan—Injection site reaction—Carmustine—melanoma	0.000322	0.00453	CcSEcCtD
Melphalan—Mouth ulceration—Dactinomycin—melanoma	0.000313	0.0044	CcSEcCtD
Melphalan—Skin exfoliation—Carmustine—melanoma	0.000309	0.00435	CcSEcCtD
Melphalan—Liver disorder—Docetaxel—melanoma	0.000305	0.00429	CcSEcCtD
Melphalan—Neuropathy—Carmustine—melanoma	0.000304	0.00428	CcSEcCtD
Melphalan—Connective tissue disorder—Vemurafenib—melanoma	0.000302	0.00425	CcSEcCtD
Melphalan—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	0.0003	0.0126	CbGpPWpGaD
Melphalan—Skin exfoliation—Temozolomide—melanoma	0.000298	0.0042	CcSEcCtD
Melphalan—Interstitial lung disease—Docetaxel—melanoma	0.000294	0.00414	CcSEcCtD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.000294	0.0123	CbGpPWpGaD
Melphalan—Neuropathy—Temozolomide—melanoma	0.000294	0.00413	CcSEcCtD
Melphalan—Neoplasm—Carmustine—melanoma	0.000293	0.00412	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—CEACAM1—melanoma	0.000284	0.0119	CbGpPWpGaD
Melphalan—Neoplasm—Temozolomide—melanoma	0.000283	0.00398	CcSEcCtD
Melphalan—Dermatitis atopic—Docetaxel—melanoma	0.000281	0.00395	CcSEcCtD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—ITGA4—melanoma	0.000281	0.0118	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—CD44—melanoma	0.000281	0.0118	CbGpPWpGaD
Melphalan—Mediastinal disorder—Vemurafenib—melanoma	0.000277	0.0039	CcSEcCtD
Melphalan—Alopecia—Vemurafenib—melanoma	0.000271	0.00382	CcSEcCtD
Melphalan—Ibuprofen—CXCL8—melanoma	0.00027	0.268	CrCbGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—ITGAV—melanoma	0.000259	0.0109	CbGpPWpGaD
Melphalan—Extravasation—Docetaxel—melanoma	0.000238	0.00335	CcSEcCtD
Melphalan—Amenorrhoea—Docetaxel—melanoma	0.000237	0.00333	CcSEcCtD
Melphalan—Hyponatraemia—Carmustine—melanoma	0.000236	0.00332	CcSEcCtD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—ITGB1—melanoma	0.000235	0.00987	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IFNG—melanoma	0.000234	0.0098	CbGpPWpGaD
Melphalan—Cough—Vemurafenib—melanoma	0.000233	0.00329	CcSEcCtD
Melphalan—Liver function test abnormal—Dactinomycin—melanoma	0.000232	0.00326	CcSEcCtD
Melphalan—Bronchospasm—Bleomycin—melanoma	0.000229	0.00322	CcSEcCtD
Melphalan—Myalgia—Vemurafenib—melanoma	0.000228	0.00321	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000226	0.00318	CcSEcCtD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ARL2—melanoma	0.000225	0.00945	CbGpPWpGaD
Melphalan—Pancytopenia—Bleomycin—melanoma	0.000221	0.00311	CcSEcCtD
Melphalan—Anaphylactic shock—Vemurafenib—melanoma	0.000218	0.00307	CcSEcCtD
Melphalan—Infection—Vemurafenib—melanoma	0.000217	0.00305	CcSEcCtD
Melphalan—Liver function test abnormal—Carmustine—melanoma	0.000217	0.00305	CcSEcCtD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—CDKN1B—melanoma	0.000212	0.0089	CbGpPWpGaD
Melphalan—Skin disorder—Vemurafenib—melanoma	0.000212	0.00298	CcSEcCtD
Melphalan—Hepatocellular injury—Docetaxel—melanoma	0.000208	0.00293	CcSEcCtD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IL2—melanoma	0.000208	0.00871	CbGpPWpGaD
Melphalan—Injection site reaction—Docetaxel—melanoma	0.000207	0.00291	CcSEcCtD
Melphalan—Pancytopenia—Dactinomycin—melanoma	0.000206	0.0029	CcSEcCtD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—ITGB3—melanoma	0.000204	0.00856	CbGpPWpGaD
Melphalan—Hypotension—Vemurafenib—melanoma	0.000204	0.00287	CcSEcCtD
Melphalan—Neutropenia—Dactinomycin—melanoma	0.000203	0.00285	CcSEcCtD
Melphalan—Stomatitis—Bleomycin—melanoma	0.000202	0.00284	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000199	0.0028	CcSEcCtD
Melphalan—Skin exfoliation—Docetaxel—melanoma	0.000199	0.00279	CcSEcCtD
Melphalan—Neuropathy—Docetaxel—melanoma	0.000195	0.00275	CcSEcCtD
Melphalan—Pancytopenia—Carmustine—melanoma	0.000193	0.00271	CcSEcCtD
Melphalan—Neutropenia—Carmustine—melanoma	0.00019	0.00267	CcSEcCtD
Melphalan—Decreased appetite—Vemurafenib—melanoma	0.00019	0.00267	CcSEcCtD
Melphalan—Stomatitis—Dactinomycin—melanoma	0.000188	0.00265	CcSEcCtD
Melphalan—Gastrointestinal disorder—Vemurafenib—melanoma	0.000188	0.00265	CcSEcCtD
Melphalan—Fatigue—Vemurafenib—melanoma	0.000188	0.00265	CcSEcCtD
Melphalan—Neoplasm—Docetaxel—melanoma	0.000188	0.00265	CcSEcCtD
Melphalan—Haemoglobin—Bleomycin—melanoma	0.000187	0.00263	CcSEcCtD
Melphalan—Ibuprofen—PPARG—melanoma	0.000186	0.185	CrCbGaD
Melphalan—Pancytopenia—Temozolomide—melanoma	0.000186	0.00262	CcSEcCtD
Melphalan—Haemorrhage—Bleomycin—melanoma	0.000186	0.00262	CcSEcCtD
Melphalan—Neutropenia—Temozolomide—melanoma	0.000183	0.00258	CcSEcCtD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—MMP1—melanoma	0.000183	0.00768	CbGpPWpGaD
Melphalan—Neuropathy peripheral—Carmustine—melanoma	0.000177	0.0025	CcSEcCtD
Melphalan—Stomatitis—Carmustine—melanoma	0.000176	0.00248	CcSEcCtD
Melphalan—Hepatitis—Dactinomycin—melanoma	0.000174	0.00244	CcSEcCtD
Melphalan—Flushing—Bleomycin—melanoma	0.000173	0.00243	CcSEcCtD
Melphalan—Neuropathy peripheral—Temozolomide—melanoma	0.000171	0.00241	CcSEcCtD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC15A2—melanoma	0.000171	0.00718	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000171	0.00716	CbGpPWpGaD
Melphalan—Stomatitis—Temozolomide—melanoma	0.00017	0.0024	CcSEcCtD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—FN1—melanoma	0.000167	0.00701	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ABCB5—melanoma	0.000165	0.00695	CbGpPWpGaD
Melphalan—Hepatobiliary disease—Temozolomide—melanoma	0.000165	0.00233	CcSEcCtD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.000165	0.00691	CbGpPWpGaD
Melphalan—Alopecia—Bleomycin—melanoma	0.000164	0.00232	CcSEcCtD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000164	0.0069	CbGpPWpGaD
Melphalan—Haemoglobin—Carmustine—melanoma	0.000163	0.0023	CcSEcCtD
Melphalan—Haemorrhage—Carmustine—melanoma	0.000162	0.00229	CcSEcCtD
Melphalan—Flushing—Dactinomycin—melanoma	0.000161	0.00227	CcSEcCtD
Melphalan—Hypersensitivity—Vemurafenib—melanoma	0.000161	0.00226	CcSEcCtD
Melphalan—Connective tissue disorder—Carmustine—melanoma	0.00016	0.00225	CcSEcCtD
Melphalan—Atrial fibrillation—Docetaxel—melanoma	0.000159	0.00224	CcSEcCtD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—EGFR—melanoma	0.000159	0.00666	CbGpPWpGaD
Melphalan—Haemoglobin—Temozolomide—melanoma	0.000158	0.00222	CcSEcCtD
Melphalan—Hepatitis—Temozolomide—melanoma	0.000157	0.00221	CcSEcCtD
Melphalan—Haemorrhage—Temozolomide—melanoma	0.000157	0.00221	CcSEcCtD
Melphalan—Asthenia—Vemurafenib—melanoma	0.000157	0.0022	CcSEcCtD
Melphalan—Urinary tract disorder—Temozolomide—melanoma	0.000155	0.00218	CcSEcCtD
Melphalan—Pruritus—Vemurafenib—melanoma	0.000154	0.00217	CcSEcCtD
Melphalan—Connective tissue disorder—Temozolomide—melanoma	0.000154	0.00217	CcSEcCtD
Melphalan—Urethral disorder—Temozolomide—melanoma	0.000154	0.00217	CcSEcCtD
Melphalan—Alopecia—Dactinomycin—melanoma	0.000153	0.00216	CcSEcCtD
Melphalan—Hyponatraemia—Docetaxel—melanoma	0.000152	0.00213	CcSEcCtD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—TNF—melanoma	0.000151	0.00635	CbGpPWpGaD
Melphalan—Flushing—Carmustine—melanoma	0.000151	0.00212	CcSEcCtD
Melphalan—Anaemia—Bleomycin—melanoma	0.00015	0.00211	CcSEcCtD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.00015	0.00628	CbGpPWpGaD
Melphalan—Diarrhoea—Vemurafenib—melanoma	0.000149	0.0021	CcSEcCtD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000149	0.00626	CbGpPWpGaD
Melphalan—Flushing—Temozolomide—melanoma	0.000146	0.00205	CcSEcCtD
Melphalan—Arrhythmia—Carmustine—melanoma	0.000145	0.00204	CcSEcCtD
Melphalan—Leukopenia—Bleomycin—melanoma	0.000145	0.00204	CcSEcCtD
Melphalan—Alopecia—Carmustine—melanoma	0.000144	0.00202	CcSEcCtD
Melphalan—Immune system disorder—Temozolomide—melanoma	0.000142	0.002	CcSEcCtD
Melphalan—Mediastinal disorder—Temozolomide—melanoma	0.000142	0.00199	CcSEcCtD
Melphalan—Cough—Bleomycin—melanoma	0.000141	0.00199	CcSEcCtD
Melphalan—Anaemia—Dactinomycin—melanoma	0.00014	0.00197	CcSEcCtD
Melphalan—Liver function test abnormal—Docetaxel—melanoma	0.000139	0.00196	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—BSG—melanoma	0.000139	0.00583	CbGpPWpGaD
Melphalan—Vomiting—Vemurafenib—melanoma	0.000139	0.00195	CcSEcCtD
Melphalan—Alopecia—Temozolomide—melanoma	0.000139	0.00195	CcSEcCtD
Melphalan—Myalgia—Bleomycin—melanoma	0.000138	0.00194	CcSEcCtD
Melphalan—Chest pain—Bleomycin—melanoma	0.000138	0.00194	CcSEcCtD
Melphalan—Rash—Vemurafenib—melanoma	0.000138	0.00194	CcSEcCtD
Melphalan—Dermatitis—Vemurafenib—melanoma	0.000137	0.00194	CcSEcCtD
Melphalan—Leukopenia—Dactinomycin—melanoma	0.000135	0.0019	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—IFNA5—melanoma	0.000135	0.00565	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.000134	0.00563	CbGpPWpGaD
Melphalan—Oedema—Bleomycin—melanoma	0.000132	0.00186	CcSEcCtD
Melphalan—Anaphylactic shock—Bleomycin—melanoma	0.000132	0.00186	CcSEcCtD
Melphalan—Infection—Bleomycin—melanoma	0.000131	0.00185	CcSEcCtD
Melphalan—Anaemia—Carmustine—melanoma	0.000131	0.00184	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—FLNA—melanoma	0.000131	0.00548	CbGpPWpGaD
Melphalan—Nausea—Vemurafenib—melanoma	0.00013	0.00182	CcSEcCtD
Melphalan—Thrombocytopenia—Bleomycin—melanoma	0.000129	0.00182	CcSEcCtD
Melphalan—Myalgia—Dactinomycin—melanoma	0.000129	0.00181	CcSEcCtD
Melphalan—Bronchospasm—Docetaxel—melanoma	0.000128	0.00181	CcSEcCtD
Melphalan—Leukopenia—Carmustine—melanoma	0.000127	0.00178	CcSEcCtD
Melphalan—Anaemia—Temozolomide—melanoma	0.000126	0.00178	CcSEcCtD
Melphalan—Anorexia—Bleomycin—melanoma	0.000126	0.00177	CcSEcCtD
Melphalan—Pancytopenia—Docetaxel—melanoma	0.000124	0.00174	CcSEcCtD
Melphalan—Hypotension—Bleomycin—melanoma	0.000124	0.00174	CcSEcCtD
Melphalan—Oedema—Dactinomycin—melanoma	0.000123	0.00174	CcSEcCtD
Melphalan—Convulsion—Carmustine—melanoma	0.000123	0.00172	CcSEcCtD
Melphalan—Infection—Dactinomycin—melanoma	0.000123	0.00172	CcSEcCtD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—PIK3CB—melanoma	0.000122	0.00514	CbGpPWpGaD
Melphalan—Leukopenia—Temozolomide—melanoma	0.000122	0.00172	CcSEcCtD
Melphalan—Neutropenia—Docetaxel—melanoma	0.000122	0.00172	CcSEcCtD
Melphalan—Thrombocytopenia—Dactinomycin—melanoma	0.000121	0.0017	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Bleomycin—melanoma	0.00012	0.0017	CcSEcCtD
Melphalan—Chest pain—Carmustine—melanoma	0.00012	0.00169	CcSEcCtD
Melphalan—Myalgia—Carmustine—melanoma	0.00012	0.00169	CcSEcCtD
Melphalan—Cough—Temozolomide—melanoma	0.000119	0.00168	CcSEcCtD
Melphalan—Paraesthesia—Bleomycin—melanoma	0.000119	0.00167	CcSEcCtD
Melphalan—Convulsion—Temozolomide—melanoma	0.000118	0.00167	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—CLU—melanoma	0.000118	0.00496	CbGpPWpGaD
Melphalan—Dyspnoea—Bleomycin—melanoma	0.000118	0.00166	CcSEcCtD
Melphalan—Anorexia—Dactinomycin—melanoma	0.000118	0.00165	CcSEcCtD
Melphalan—Myalgia—Temozolomide—melanoma	0.000116	0.00164	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—RHOB—melanoma	0.000116	0.00485	CbGpPWpGaD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000116	0.00163	CcSEcCtD
Melphalan—Oedema—Carmustine—melanoma	0.000115	0.00162	CcSEcCtD
Melphalan—Decreased appetite—Bleomycin—melanoma	0.000115	0.00162	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ARL2—melanoma	0.000115	0.00481	CbGpPWpGaD
Melphalan—Infection—Carmustine—melanoma	0.000115	0.00161	CcSEcCtD
Melphalan—Neuropathy peripheral—Docetaxel—melanoma	0.000114	0.0016	CcSEcCtD
Melphalan—Stomatitis—Docetaxel—melanoma	0.000113	0.0016	CcSEcCtD
Melphalan—Jaundice—Docetaxel—melanoma	0.000113	0.0016	CcSEcCtD
Melphalan—Pain—Bleomycin—melanoma	0.000113	0.00159	CcSEcCtD
Melphalan—Thrombocytopenia—Carmustine—melanoma	0.000113	0.00159	CcSEcCtD
Melphalan—Tachycardia—Carmustine—melanoma	0.000113	0.00159	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000112	0.00158	CcSEcCtD
Melphalan—Anaphylactic shock—Temozolomide—melanoma	0.000112	0.00157	CcSEcCtD
Melphalan—Oedema—Temozolomide—melanoma	0.000112	0.00157	CcSEcCtD
Melphalan—Infection—Temozolomide—melanoma	0.000111	0.00156	CcSEcCtD
Melphalan—Anorexia—Carmustine—melanoma	0.00011	0.00155	CcSEcCtD
Melphalan—Hepatobiliary disease—Docetaxel—melanoma	0.00011	0.00155	CcSEcCtD
Melphalan—Thrombocytopenia—Temozolomide—melanoma	0.000109	0.00154	CcSEcCtD
Melphalan—Skin disorder—Temozolomide—melanoma	0.000108	0.00153	CcSEcCtD
Melphalan—Hypotension—Carmustine—melanoma	0.000108	0.00152	CcSEcCtD
Melphalan—Decreased appetite—Dactinomycin—melanoma	0.000107	0.00151	CcSEcCtD
Melphalan—Fatigue—Dactinomycin—melanoma	0.000106	0.0015	CcSEcCtD
Melphalan—Anorexia—Temozolomide—melanoma	0.000106	0.0015	CcSEcCtD
Melphalan—Pain—Dactinomycin—melanoma	0.000105	0.00148	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Carmustine—melanoma	0.000105	0.00148	CcSEcCtD
Melphalan—Urticaria—Bleomycin—melanoma	0.000105	0.00148	CcSEcCtD
Melphalan—Haemoglobin—Docetaxel—melanoma	0.000105	0.00148	CcSEcCtD
Melphalan—Hepatitis—Docetaxel—melanoma	0.000104	0.00147	CcSEcCtD
Melphalan—Haemorrhage—Docetaxel—melanoma	0.000104	0.00147	CcSEcCtD
Melphalan—Paraesthesia—Carmustine—melanoma	0.000104	0.00146	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—RAC2—melanoma	0.000104	0.00435	CbGpPWpGaD
Melphalan—Urinary tract disorder—Docetaxel—melanoma	0.000103	0.00145	CcSEcCtD
Melphalan—Dyspnoea—Carmustine—melanoma	0.000103	0.00145	CcSEcCtD
Melphalan—Connective tissue disorder—Docetaxel—melanoma	0.000103	0.00144	CcSEcCtD
Melphalan—Urethral disorder—Docetaxel—melanoma	0.000102	0.00144	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—VEGFC—melanoma	0.000102	0.00428	CbGpPWpGaD
Melphalan—Musculoskeletal discomfort—Temozolomide—melanoma	0.000102	0.00143	CcSEcCtD
Melphalan—Decreased appetite—Carmustine—melanoma	0.0001	0.00141	CcSEcCtD
Melphalan—Paraesthesia—Temozolomide—melanoma	0.0001	0.00141	CcSEcCtD
Melphalan—Gastrointestinal disorder—Carmustine—melanoma	9.97e-05	0.0014	CcSEcCtD
Melphalan—Dyspnoea—Temozolomide—melanoma	9.94e-05	0.0014	CcSEcCtD
Melphalan—Pain—Carmustine—melanoma	9.87e-05	0.00139	CcSEcCtD
Melphalan—Dyspepsia—Temozolomide—melanoma	9.82e-05	0.00138	CcSEcCtD
Melphalan—Hypersensitivity—Bleomycin—melanoma	9.74e-05	0.00137	CcSEcCtD
Melphalan—Decreased appetite—Temozolomide—melanoma	9.7e-05	0.00136	CcSEcCtD
Melphalan—Flushing—Docetaxel—melanoma	9.69e-05	0.00136	CcSEcCtD
Melphalan—Gastrointestinal disorder—Temozolomide—melanoma	9.63e-05	0.00136	CcSEcCtD
Melphalan—Fatigue—Temozolomide—melanoma	9.62e-05	0.00135	CcSEcCtD
Melphalan—Pain—Temozolomide—melanoma	9.54e-05	0.00134	CcSEcCtD
Melphalan—Asthenia—Bleomycin—melanoma	9.49e-05	0.00134	CcSEcCtD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—NRAS—melanoma	9.44e-05	0.00396	CbGpPWpGaD
Melphalan—Immune system disorder—Docetaxel—melanoma	9.43e-05	0.00133	CcSEcCtD
Melphalan—Mediastinal disorder—Docetaxel—melanoma	9.41e-05	0.00132	CcSEcCtD
Melphalan—Pruritus—Bleomycin—melanoma	9.36e-05	0.00132	CcSEcCtD
Melphalan—Arrhythmia—Docetaxel—melanoma	9.33e-05	0.00131	CcSEcCtD
Melphalan—Alopecia—Docetaxel—melanoma	9.23e-05	0.0013	CcSEcCtD
Melphalan—Hypersensitivity—Dactinomycin—melanoma	9.09e-05	0.00128	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—SPARC—melanoma	8.95e-05	0.00376	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—F2R—melanoma	8.95e-05	0.00376	CbGpPWpGaD
Melphalan—Urticaria—Temozolomide—melanoma	8.86e-05	0.00125	CcSEcCtD
Melphalan—Asthenia—Dactinomycin—melanoma	8.85e-05	0.00125	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC15A2—melanoma	8.69e-05	0.00365	CbGpPWpGaD
Melphalan—Hypersensitivity—Carmustine—melanoma	8.5e-05	0.0012	CcSEcCtD
Melphalan—Diarrhoea—Dactinomycin—melanoma	8.44e-05	0.00119	CcSEcCtD
Melphalan—Vomiting—Bleomycin—melanoma	8.41e-05	0.00118	CcSEcCtD
Melphalan—Anaemia—Docetaxel—melanoma	8.4e-05	0.00118	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—HSPA5—melanoma	8.38e-05	0.00352	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC17A5—melanoma	8.37e-05	0.00351	CbGpPWpGaD
Melphalan—Rash—Bleomycin—melanoma	8.34e-05	0.00117	CcSEcCtD
Melphalan—Dermatitis—Bleomycin—melanoma	8.33e-05	0.00117	CcSEcCtD
Melphalan—Asthenia—Carmustine—melanoma	8.28e-05	0.00117	CcSEcCtD
Melphalan—Hypersensitivity—Temozolomide—melanoma	8.22e-05	0.00116	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—GAB2—melanoma	8.19e-05	0.00344	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—GNA11—melanoma	8.19e-05	0.00344	CbGpPWpGaD
Melphalan—Leukopenia—Docetaxel—melanoma	8.14e-05	0.00115	CcSEcCtD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—KRAS—melanoma	8.12e-05	0.00341	CbGpPWpGaD
Melphalan—Asthenia—Temozolomide—melanoma	8e-05	0.00113	CcSEcCtD
Melphalan—Cough—Docetaxel—melanoma	7.93e-05	0.00112	CcSEcCtD
Melphalan—Diarrhoea—Carmustine—melanoma	7.9e-05	0.00111	CcSEcCtD
Melphalan—Pruritus—Temozolomide—melanoma	7.89e-05	0.00111	CcSEcCtD
Melphalan—Convulsion—Docetaxel—melanoma	7.88e-05	0.00111	CcSEcCtD
Melphalan—Ibuprofen—PTGS2—melanoma	7.87e-05	0.078	CrCbGaD
Melphalan—Nausea—Bleomycin—melanoma	7.85e-05	0.00111	CcSEcCtD
Melphalan—Vomiting—Dactinomycin—melanoma	7.84e-05	0.0011	CcSEcCtD
Melphalan—Rash—Dactinomycin—melanoma	7.78e-05	0.00109	CcSEcCtD
Melphalan—Chest pain—Docetaxel—melanoma	7.74e-05	0.00109	CcSEcCtD
Melphalan—Myalgia—Docetaxel—melanoma	7.74e-05	0.00109	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—HDAC2—melanoma	7.7e-05	0.00323	CbGpPWpGaD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	7.68e-05	0.00108	CcSEcCtD
Melphalan—Diarrhoea—Temozolomide—melanoma	7.63e-05	0.00107	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—GNAQ—melanoma	7.61e-05	0.00319	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—ITGA4—melanoma	7.61e-05	0.00319	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—CD44—melanoma	7.61e-05	0.00319	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC6A11—melanoma	7.6e-05	0.00319	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—IFNB1—melanoma	7.56e-05	0.00317	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—PIK3CA—melanoma	7.46e-05	0.00313	CbGpPWpGaD
Melphalan—Oedema—Docetaxel—melanoma	7.42e-05	0.00104	CcSEcCtD
Melphalan—Anaphylactic shock—Docetaxel—melanoma	7.42e-05	0.00104	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—IFNA1—melanoma	7.37e-05	0.00309	CbGpPWpGaD
Melphalan—Infection—Docetaxel—melanoma	7.37e-05	0.00104	CcSEcCtD
Melphalan—Vomiting—Carmustine—melanoma	7.34e-05	0.00103	CcSEcCtD
Melphalan—Nausea—Dactinomycin—melanoma	7.33e-05	0.00103	CcSEcCtD
Melphalan—Rash—Carmustine—melanoma	7.28e-05	0.00102	CcSEcCtD
Melphalan—Dermatitis—Carmustine—melanoma	7.27e-05	0.00102	CcSEcCtD
Melphalan—Thrombocytopenia—Docetaxel—melanoma	7.26e-05	0.00102	CcSEcCtD
Melphalan—Tachycardia—Docetaxel—melanoma	7.24e-05	0.00102	CcSEcCtD
Melphalan—Skin disorder—Docetaxel—melanoma	7.21e-05	0.00101	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—SYK—melanoma	7.16e-05	0.003	CbGpPWpGaD
Melphalan—Vomiting—Temozolomide—melanoma	7.09e-05	0.000998	CcSEcCtD
Melphalan—Anorexia—Docetaxel—melanoma	7.07e-05	0.000995	CcSEcCtD
Melphalan—Rash—Temozolomide—melanoma	7.03e-05	0.00099	CcSEcCtD
Melphalan—Dermatitis—Temozolomide—melanoma	7.03e-05	0.000989	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—ITGAV—melanoma	7.02e-05	0.00295	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—AKT3—melanoma	7.02e-05	0.00295	CbGpPWpGaD
Melphalan—Ibuprofen—ALB—melanoma	7.01e-05	0.0695	CrCbGaD
Melphalan—Hypotension—Docetaxel—melanoma	6.93e-05	0.000976	CcSEcCtD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—HRAS—melanoma	6.9e-05	0.0029	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—IFNA2—melanoma	6.86e-05	0.00288	CbGpPWpGaD
Melphalan—Nausea—Carmustine—melanoma	6.86e-05	0.000965	CcSEcCtD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC5A5—melanoma	6.84e-05	0.00287	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC5A5—melanoma	6.82e-05	0.00286	CbGpPWpGaD
Melphalan—Musculoskeletal discomfort—Docetaxel—melanoma	6.76e-05	0.000951	CcSEcCtD
Melphalan—Ibuprofen—ABCB1—melanoma	6.69e-05	0.0664	CrCbGaD
Melphalan—Paraesthesia—Docetaxel—melanoma	6.66e-05	0.000938	CcSEcCtD
Melphalan—Nausea—Temozolomide—melanoma	6.63e-05	0.000933	CcSEcCtD
Melphalan—Dyspnoea—Docetaxel—melanoma	6.61e-05	0.000931	CcSEcCtD
Melphalan—Dyspepsia—Docetaxel—melanoma	6.53e-05	0.000919	CcSEcCtD
Melphalan—Decreased appetite—Docetaxel—melanoma	6.45e-05	0.000908	CcSEcCtD
Melphalan—Gastrointestinal disorder—Docetaxel—melanoma	6.4e-05	0.000902	CcSEcCtD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—ALB—melanoma	6.4e-05	0.00269	CbGpPWpGaD
Melphalan—Fatigue—Docetaxel—melanoma	6.4e-05	0.0009	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—ITGB1—melanoma	6.38e-05	0.00268	CbGpPWpGaD
Melphalan—Pain—Docetaxel—melanoma	6.34e-05	0.000893	CcSEcCtD
Melphalan—SLC22A3—Metabolism—ACER3—melanoma	5.87e-05	0.00247	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—HGF—melanoma	5.83e-05	0.00245	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—CSF2—melanoma	5.77e-05	0.00242	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PRKCA—melanoma	5.53e-05	0.00232	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—ITGB3—melanoma	5.53e-05	0.00232	CbGpPWpGaD
Melphalan—Hypersensitivity—Docetaxel—melanoma	5.47e-05	0.000769	CcSEcCtD
Melphalan—SLC22A3—Metabolism—UGT2B10—melanoma	5.37e-05	0.00225	CbGpPWpGaD
Melphalan—Asthenia—Docetaxel—melanoma	5.32e-05	0.000749	CcSEcCtD
Melphalan—Pruritus—Docetaxel—melanoma	5.25e-05	0.000739	CcSEcCtD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ABCB1—melanoma	5.2e-05	0.00218	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—RAC1—melanoma	5.13e-05	0.00215	CbGpPWpGaD
Melphalan—Diarrhoea—Docetaxel—melanoma	5.08e-05	0.000714	CcSEcCtD
Melphalan—SLC22A3—Metabolism—HS3ST5—melanoma	4.99e-05	0.0021	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—MMP1—melanoma	4.96e-05	0.00208	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—CDK2—melanoma	4.87e-05	0.00204	CbGpPWpGaD
Melphalan—Vomiting—Docetaxel—melanoma	4.72e-05	0.000664	CcSEcCtD
Melphalan—Rash—Docetaxel—melanoma	4.68e-05	0.000658	CcSEcCtD
Melphalan—Dermatitis—Docetaxel—melanoma	4.67e-05	0.000658	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—FN1—melanoma	4.53e-05	0.0019	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—NOS2—melanoma	4.47e-05	0.00188	CbGpPWpGaD
Melphalan—Nausea—Docetaxel—melanoma	4.41e-05	0.00062	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—PIK3CG—melanoma	4.33e-05	0.00182	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—EGF—melanoma	4.28e-05	0.0018	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—IGF1—melanoma	3.97e-05	0.00166	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PIK3CD—melanoma	3.81e-05	0.0016	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PLCB4—melanoma	3.79e-05	0.00159	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—ALB—melanoma	3.76e-05	0.00158	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PIP4K2A—melanoma	3.56e-05	0.00149	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—SLC6A11—melanoma	3.56e-05	0.00149	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC5A5—melanoma	3.47e-05	0.00146	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—MTAP—melanoma	3.46e-05	0.00145	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PIK3CB—melanoma	3.32e-05	0.00139	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—ALB—melanoma	3.26e-05	0.00137	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ALB—melanoma	3.25e-05	0.00137	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PHGDH—melanoma	3.09e-05	0.0013	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—LUM—melanoma	3.09e-05	0.0013	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—IL2—melanoma	3.05e-05	0.00128	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—HPSE—melanoma	3.03e-05	0.00127	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CUBN—melanoma	2.97e-05	0.00125	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—SDHD—melanoma	2.87e-05	0.0012	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—BSG—melanoma	2.87e-05	0.0012	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CSPG4—melanoma	2.87e-05	0.0012	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GPAM—melanoma	2.78e-05	0.00117	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ABCB1—melanoma	2.65e-05	0.00111	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—VEGFA—melanoma	2.59e-05	0.00109	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—NRAS—melanoma	2.56e-05	0.00107	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—MAPK3—melanoma	2.45e-05	0.00103	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PLA2G6—melanoma	2.36e-05	0.000992	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—MAPK1—melanoma	2.33e-05	0.000979	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—KRAS—melanoma	2.2e-05	0.000924	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—VCAN—melanoma	2.12e-05	0.000891	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PIK3CA—melanoma	2.02e-05	0.000849	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—TP53—melanoma	1.96e-05	0.000822	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—HRAS—melanoma	1.87e-05	0.000786	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CYP17A1—melanoma	1.79e-05	0.000751	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GNA11—melanoma	1.69e-05	0.00071	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ALB—melanoma	1.66e-05	0.000696	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—FASN—melanoma	1.65e-05	0.000694	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—AKT1—melanoma	1.65e-05	0.000694	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—SLC5A5—melanoma	1.63e-05	0.000683	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GNAQ—melanoma	1.57e-05	0.00066	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CD44—melanoma	1.57e-05	0.00066	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CYP1B1—melanoma	1.51e-05	0.000632	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ABCB1—melanoma	1.24e-05	0.000521	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PRKCA—melanoma	1.14e-05	0.000479	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ERCC2—melanoma	1.13e-05	0.000475	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PIK3CG—melanoma	8.95e-06	0.000375	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PPARG—melanoma	8.63e-06	0.000362	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PIK3CD—melanoma	7.86e-06	0.00033	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ALB—melanoma	7.76e-06	0.000326	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PIK3CB—melanoma	6.85e-06	0.000288	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PTGS2—melanoma	6.79e-06	0.000285	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PTEN—melanoma	5.92e-06	0.000249	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PIK3CA—melanoma	4.18e-06	0.000175	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—AKT1—melanoma	3.41e-06	0.000143	CbGpPWpGaD
